• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming

    11/11/25 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials
    Get the next $EVGN alert in real time by email

    Collaboration focuses on integrating high-yield castor varieties with advanced mechanized solutions, including harvesting and threshing technologies

    REHOVOT, Israel and MANTOVA, Italy, Nov. 11, 2025 /PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an Israeli developer of high-yield castor seed varieties and integrated castor farming solutions — and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), and Fantini Italia S.R.L. ("Fantini"), a leading Italian developer and manufacturer of agricultural harvesting equipment, today announced a strategic collaboration for large-scale, commercial castor cultivation through advanced mechanization technologies.

    Evogene Logo

     

    Casterra Logo

    The partnership is designed to meet the rising global demand for castor oil used for the production of biofuels and bio-based industrial products, by developing comprehensive and scalable farming solutions that integrate specially bred castor varieties with cutting-edge farm machinery.

    The global castor oil and derivatives market is currently valued at approximately USD 2.4 billion and is expected to reach USD 3.09 billion by 2030, advancing at a 5.20% CAGR[1]. Castor oil and its derivatives are utilized across a wide range of industries, including lubricants, surface coatings, cosmetics, pharmaceuticals, plastics, resins, and increasingly in biofuels.

    In recent years, global efforts have intensified to modernize castor farming with mechanized, economically viable systems capable of supporting high-volume, industrial-scale production. The collaboration between Casterra and Fantini directly addresses one of the key challenges in this initiative: bridging the gap between plant genetics and farm mechanization. Casterra's proprietary high-yield castor varieties are specially developed for industrial-scale cultivation and are well-suited to work with Fantini's high-capacity, precision harvesting and threshing technologies. Together, the companies will develop and tailor integrated solutions to serve multiple geographical markets and farming conditions worldwide.

    Mr. Yoash Zohar, CEO of Casterra, stated: "This collaboration with Fantini represents true synergy and significantly strengthens our global offering. Fantini brings decades of expertise in the development of agricultural machinery, and combined with our unique castor varieties, we're enabling a breakthrough in castor cultivation. We believe this partnership will play a key role in positioning castor as a sustainable and scalable feedstock for the growing biofuel and bio-based products industries."

    Mr Nicola Bonacini, CEO of Fantini Italia S.R.L., added: having a serious partner like Casterra means a great deal for Fantini's Team: it means being able to draw on years of experience, being able to count on their skilled consultants to implement our protocols and procedures, and above all, having the opportunity to improve our machines in collaboration with their best customers. Furthermore, like Casterra, Fantini is also committed to producing agricultural machinery with the lowest possible environmental impact, and according to our estimates, Fantini's solutions currently allow for a reduction in carbon footprint of about two-thirds compared to the most widely actual used solutions.

    About Casterra Ag Ltd.: 

    Casterra, a wholly owned subsidiary of Evogene, is empowering sustainable agriculture through elite castor seed varieties and development of advanced castor farming systems. Casterra leverages advanced genomic capabilities (licensed from Evogene) with its global breeding network to deliver high-yield castor seeds for the bio-based industries. Building on its elite castor seed varieties, Casterra combines agronomic expertise to develop advanced castor farming systems worldwide, tailored to diverse growing conditions, supporting farmers and industries in achieving sustainable production goals while advancing bio-based solutions.

    For more information, please visit http://www.casterra.co 

    About Evogene Ltd.: 

    Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries.

    At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs.

    Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. We call this approach "Real-World Innovation".

    Learn more at: www.evogene.com.

    About Fantini Italia S.R.L.: 

    Fantini Italia srl is an American-owned company headquartered in Italy. Since 1968 Fantini Italia SRL has been manufacturing the highest quality of grain and other crops harvesting machineries. During these 60 years of activity, Fantini has pioneered the market with a completely new vision of harvesting introducing the first folding corn header, the first sunflower harvesting header in 1990, the first harvesting headers and processing appliances for castor beans in 2016, and in 2025 the brand new patented folding direct cut heads for forage harvesters designed for harvesting forage and biomass. Fantini has always been committed to producing equipment that can reduce environmental impact, carbon footprint and fossil fuel consumption: the new castor bean and forage machines are indeed designed to harvest plants for the production of biofuels and/or biomass for biogas production plants.

    Lean more about Fantini Italia SRL on: www.fantiniworld.com

    Forward-Looking Statements

    This press release contains "forward-looking statements" relating to future events. These statements may be identified by words such as "may", "could", "expects", "hopes" "intends", "anticipates", "plans", "believes", "scheduled", "estimates", "demonstrates" or words of similar meaning. For example, Evogene and its subsidiaries are using forward-looking statements in this press release when they discuss: the success of Fantini and Casterra in developing comprehensive and scalable farming solutions that integrate specially bred castor varieties with cutting-edge farm machinery, their success in bridging the gap between plant genetics and farm mechanization, Fantini's solutions ability to reduce carbon footprint.  Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance, or achievements of Evogene and its subsidiaries may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which are beyond the control of Evogene and its subsidiaries, including, without limitation, the current war between Israel, Hamas and Hezbollah and any worsening of the situation in Israel such as further mobilizations or escalation in the northern border of Israel, and those risk factors contained in Evogene's reports filed with the applicable securities authority. In addition, Evogene and its subsidiaries rely, and expect to continue to rely, on third parties to conduct certain activities, such as their field trials and pre-clinical studies, and if these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected deadlines, Evogene and its subsidiaries may experience significant delays in the conduct of their activities. Evogene and its subsidiaries disclaim any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.

    Evogene Investors Relations Contact:

    Email: [email protected]

    Tel: +972-8-9311901

    Fantini Investors Relations Contact: 

    Email: [email protected]

    Tel: +39 0376 868202

    [1] https://www.mordorintelligence.com/industry-reports/castor-oil-market

    Logo - https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg

    Logo - https://mma.prnewswire.com/media/1947467/Casterra.jpg

    Cision View original content:https://www.prnewswire.com/news-releases/casterra-and-fantini-partner-to-advance-agricultural-mechanization-for-scalable-commercial-castor-farming-302611398.html

    SOURCE Casterra Ag Ltd.

    Get the next $EVGN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVGN

    DatePrice TargetRatingAnalyst
    11/24/2021$8.00 → $7.00Outperform
    RBC Capital
    10/8/2021$7.00Buy
    ROTH Capital
    8/23/2021$8.00Outperform
    RBC Capital
    7/29/2021$10.00Buy
    Aegis Capital
    More analyst ratings

    $EVGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Evogene Reports Third Quarter 2025 Financial Results

    Conference call and webcast: today, November 20, 2025, 9:00 AM ET Financial Highlights: During the first nine months ending September 30, 2025, Evogene advanced its strategic transition toward establishing itself as a leader in computational chemistry, with a focus on the generative design of small molecules for the pharmaceutical and agricultural industries. As part of this new strategy, the company executed an organizational realignment and cost-reduction plan, most of which was completed by the end of the second quarter. The impact of these measures is reflected in the third-quarter results, with total operating expenses, net, of approximately $2.9 million compared to approximately $6.6 m

    11/20/25 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming

    Collaboration focuses on integrating high-yield castor varieties with advanced mechanized solutions, including harvesting and threshing technologies REHOVOT, Israel and MANTOVA, Italy, Nov. 11, 2025 /PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an Israeli developer of high-yield castor seed varieties and integrated castor farming solutions — and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), and Fantini Italia S.R.L. ("Fantini"), a leading Italian developer and manufacturer of agricultural harvesting equipment, today announced a strategic collaboration for large-scale, commercial castor cultivation through advanced mechanization technologies.   The partnership is designed to meet

    11/11/25 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Evogene Schedules Third Quarter 2025 Financial Results Release

    Zoom conference call scheduled for November 20, 2025, 9:00 AM ET REHOVOT, Israel, Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the third quarter of 2025, on Thursday, November 20, 2025. Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To attend the conf

    11/6/25 9:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    $EVGN
    SEC Filings

    View All

    SEC Form 6-K filed by Evogene Ltd

    6-K - Evogene Ltd. (0001574565) (Filer)

    11/20/25 7:00:22 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    SEC Form EFFECT filed by Evogene Ltd

    EFFECT - Evogene Ltd. (0001574565) (Filer)

    11/20/25 12:15:15 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    SEC Form POS AM filed by Evogene Ltd

    POS AM - Evogene Ltd. (0001574565) (Filer)

    9/30/25 7:16:05 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    $EVGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital reiterated coverage on EverGen Infrastructure with a new price target

    RBC Capital reiterated coverage of EverGen Infrastructure with a rating of Outperform and set a new price target of $7.00 from $8.00 previously

    11/24/21 7:31:39 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    ROTH Capital initiated coverage on Evogene with a new price target

    ROTH Capital initiated coverage of Evogene with a rating of Buy and set a new price target of $7.00

    10/8/21 8:30:09 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    RBC Capital initiated coverage on EverGen Infrastructure Corp. with a new price target

    RBC Capital initiated coverage of EverGen Infrastructure Corp. with a rating of Outperform and set a new price target of $8.00

    8/23/21 11:09:14 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    $EVGN
    Financials

    Live finance-specific insights

    View All

    Evogene Schedules Third Quarter 2025 Financial Results Release

    Zoom conference call scheduled for November 20, 2025, 9:00 AM ET REHOVOT, Israel, Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the third quarter of 2025, on Thursday, November 20, 2025. Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To attend the conf

    11/6/25 9:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Evogene Reports Second Quarter 2025 Financial Results

    Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: The financial results for the first half of 2025 of Lavie Bio, a subsidiary of Evogene and the MicroBoost AI for Ag operations, are presented as a single-line item in Evogene's consolidated statements of profit and loss for the first half of 2025. Their results are included under the line titled - "Loss from operations held for sale, net". This accounting treatment follows the intention to sell the majority of Lavie Bio's activities and the MicroBoost AI for Ag as of June 30, 2025.In the first half of 2025, total revenues amounted to approximately $3.2 million, compared to $2.3 million in the first half of

    8/19/25 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Evogene Schedules Second Quarter 2025 Financial Results Release

    Zoom conference call scheduled for August 19, 2025, 9:00 AM ET REHOVOT, Israel, July 29, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Tuesday, August 19, 2025.   Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To attend the conference, please register in advance: https://www.veidan-conferencing.com/evogene The entire conference will be available online on the company's website a few day

    7/29/25 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    $EVGN
    Leadership Updates

    Live Leadership Updates

    View All

    Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases

    A failure in metabolite breakdown leads to their ordered self-assembly into pathological aggregates, such as in Tyrosinemia and Gout. REHOVOT, Israel, Aug. 12, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq, TASE: EVGN), a leading computational biology and chemistry company, today announced a scientific collaboration with the pioneering research group of Professor Ehud Gazit from Tel Aviv University, a world leader in the field of molecular self-assembly. This collaboration agreement was facilitated by Ramot, Tel Aviv University's tech transfer company. This partnership aims to accelerate the discovery and optimization of novel small molecules as potential drug candidates for a range of diseases

    8/12/25 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025

    Mr. Nir Nirmodi is Replacing Ms. Sarit Firon, who will Continue Serving as a Member of the Board REHOVOT, Israel, March 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development, today announced the appointment of Mr. Nir Nimrodi as the new Chairperson of the Board, succeeding Ms. Sarit Firon, who has held the position since August 2021. Ms. Firon will continue to serve as a member of the Board. As Evogene progresses toward key milestones across its subsidiaries and programs, Mr. Nimrodi's extensive experience in scaling life sciences businesses and driving growth make

    3/6/25 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation

    Mr. Yoash Zohar, a seasoned ag executive, is joining Casterra as CEO to lead the company's significant operational expansion REHOVOT, Israel, Dec. 19, 2023 /PRNewswire/ -- Casterra Ag Ltd., a subsidiary of Evogene Ltd. ("Evogene") (NASDAQ:EVGN) (TASE: EVGN) and an integrated castor cultivation solution company for the bio-based industries (e.g. biofuels, biopolymers), today announced the appointment of Mr. Yoash Zohar as new CEO, as of January 1, 2024, to lead the company's expansion efforts. Considering Casterra's rapid growth and its continued prospects for development, this nomination aims to strengthen its leadership and positioning in the industry. Casterra entered a new phase in its l

    12/19/23 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    $EVGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evogene Ltd

    SC 13G/A - Evogene Ltd. (0001574565) (Subject)

    10/15/24 6:52:26 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by Evogene Ltd

    SC 13G - Evogene Ltd. (0001574565) (Subject)

    2/14/24 8:30:01 PM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G/A filed by Evogene Ltd (Amendment)

    SC 13G/A - Evogene Ltd. (0001574565) (Subject)

    2/11/22 12:15:01 PM ET
    $EVGN
    Agricultural Chemicals
    Industrials